Literature DB >> 24243880

The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.

D A Lewis1.   

Abstract

Core groups contain individuals who are regularly infected with Neisseria gonorrhoeae and are able to transmit their infection to a large number of sexual partners. Classical core groups, such as sex workers and their male partners, or men who have sex with men (MSM), have contributed to the emergence and spread of antimicrobial-resistant N gonorrhoeae over many years. Sex workers and their clients were the most important core group driving the dissemination of penicillinase-producing N gonorrhoeae in the 1970s. Such individuals have continued to contribute to penicillinase-producing N gonorrhoeae outbreaks as well as to the subsequent emergence of gonococcal resistance to fluoroquinolones, macrolides, spectinomycin and cephalosporins in various settings. MSM have been a very important core group since the 1980s, first with the spread of TetM-expressing N gonorrhoeae and, second, with the dissemination of fluoroquinolone-resistant N gonorrhoeae. MSM-associated sexual networks have most recently been critical to the spread of gonococci resistant to third generation extended spectrum cephalosporins, including cefixime and ceftriaxone. Individuals within other core groups have also been linked to the transmission of antimicrobial-resistant gonorrhoea, such as military personnel, travellers, drug users, young adults, older men and members of street gangs. Understanding core behaviours and their geospatial clustering is essential for an optimal public health response to the rising prevalence of antimicrobial-resistant gonorrhoea. Furthermore, rapid and effective treatment of N gonorrhoeae infections in core individuals and their sexual partners should be a priority for gonorrhoea control programmes.

Entities:  

Keywords:  Antibiotic Resistance; Commercial Sex; Gonorrhoea; Sexual Networks

Mesh:

Substances:

Year:  2013        PMID: 24243880     DOI: 10.1136/sextrans-2013-051020

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  32 in total

Review 1.  Epidemiology of gonorrhoea: a global perspective.

Authors:  Robert D Kirkcaldy; Emily Weston; Aluisio C Segurado; Gwenda Hughes
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

2.  Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.

Authors:  Severin O Gose; Olusegun O Soge; James L Beebe; Duylinh Nguyen; Juliet E Stoltey; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2015-05       Impact factor: 2.830

3.  Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.

Authors:  Liteboho D Maduna; Marleen M Kock; Brian M J W van der Veer; Oscar Radebe; James McIntyre; Lieke B van Alphen; Remco P H Peters
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

4.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02

Review 5.  Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations.

Authors:  Deborah L Couldwell; David A Lewis
Journal:  Infect Drug Resist       Date:  2015-05-26       Impact factor: 4.003

6.  Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5.

Authors:  Odile B Harrison; James E Bray; Martin C J Maiden; Dominique A Caugant
Journal:  EBioMedicine       Date:  2015-03-01       Impact factor: 8.143

7.  Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Neisseria Genome. A Viewpoint.

Authors:  Chris Kenyon; Jolein Laumen; Sheeba Manoharan-Basil
Journal:  Antibiotics (Basel)       Date:  2021-05-01

8.  The role of sexual networks in studies of how BV and STIs increase the risk of subsequent reinfection.

Authors:  C Kenyon; J Buyze; M Klebanoff; R M Brotman
Journal:  Epidemiol Infect       Date:  2018-09-05       Impact factor: 4.434

9.  Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.

Authors:  J Buyze; W Vanden Berghe; N Hens; C Kenyon
Journal:  Epidemiol Infect       Date:  2018-02-01       Impact factor: 4.434

Review 10.  Evidence and knowledge gaps on the disease burden in sexual and gender minorities: a review of systematic reviews.

Authors:  Karel Blondeel; Lale Say; Doris Chou; Igor Toskin; Rajat Khosla; Elisa Scolaro; Marleen Temmerman
Journal:  Int J Equity Health       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.